The most common adverse events (AEs) of these three major EGFR-TKIs include skin rash, stomatitis, paronychia, and diarrhea, which are manageable with treatment interruptions or dose reduction and best supportive care [33]. This evidence concerns the gene EGFR and stomatitis.